Abstract

Neonatal screening is an essential public health measure designed to identify congenital disorders in newborns shortly after birth. This proactive approach enables the early detection of serious conditions that may not exhibit immediate symptoms but can lead to significant health complications if untreated. By screening for metabolic, endocrine, genetic, and infectious disorders, healthcare providers can initiate timely interventions that improve health outcomes and reduce the risk of long-term disabilities. This article discusses the importance of neonatal screening, the types of conditions targeted, the screening process, and the challenges in implementing effective programs. Emphasizing its role in safeguarding newborns, this article underscores the need for continued investment in neonatal screening initiatives to ensure that all infants have access to critical health interventions.